2026 Pilot Translational Award
The 2026 Pilot Translational Award from the Melanoma Research Foundation funds innovative translational melanoma research using human-derived data to generate pilot findings for future large-scale studies.
Funder: Melanoma Research Foundation
Due Dates: August 15, 2026: Application submission deadline (full application)
Funding Amounts: $50,000 total for a one-year pilot award; direct costs only; no indirect costs allowed.
Summary: Supports innovative clinical and translational melanoma research to generate findings for future multicenter studies.
Description
The Melanoma Research Foundation Breakthrough Consortium (MRFBC) Pilot Translational Award is designed to accelerate innovative clinical and translational research in melanoma. This one-year, $50,000 award supports projects that leverage human specimens, macromolecules derived from human tissue, or patient-reported outcomes to generate novel findings. The ultimate goal is to produce pilot data that can lead to larger, multicenter studies, with a particular emphasis on correlative or bioinformatic work that complements clinical trials. The program fosters collaboration and scientific rigor across the MRFBC’s national network of 33 melanoma centers of excellence.
